{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:35:23Z","timestamp":1782956123097,"version":"3.54.5"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2016-I2M-2-001"],"award-info":[{"award-number":["2016-I2M-2-001"]}]},{"DOI":"10.13039\/501100004826","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["7202150"],"award-info":[{"award-number":["7202150"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["19JCZDJC64200"],"award-info":[{"award-number":["19JCZDJC64200"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program","award":["2019ZLH101"],"award-info":[{"award-number":["2019ZLH101"]}]},{"name":"Graduate Innovation Fund of the Chinese Academy of Medical Sciences and Peking Union Medical College","award":["2019-1002-73"],"award-info":[{"award-number":["2019-1002-73"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma (GBM) is the most malignant and lethal intracranial tumor, with extremely limited treatment options. Immunotherapy has been widely studied in GBM, but none can significantly prolong the overall survival (OS) of patients without selection. Considering that GBM cancer stem cells (CSCs) play a non-negligible role in tumorigenesis and chemoradiotherapy resistance, we proposed a novel stemness-based classification of GBM and screened out certain population more responsive to immunotherapy. The one-class logistic regression algorithm was used to calculate the stemness index (mRNAsi) of 518 GBM patients from The Cancer Genome Atlas (TCGA) database based on transcriptomics of GBM and pluripotent stem cells. Based on their stemness signature, GBM patients were divided into two subtypes via consensus clustering, and patients in Stemness Subtype I presented significantly better OS but poorer progression-free survival than Stemness Subtype II. Genomic variations revealed patients in Stemness Subtype I had higher somatic mutation loads and copy number alteration burdens. Additionally, two stemness subtypes had distinct tumor immune microenvironment patterns. Tumor Immune Dysfunction and Exclusion and subclass mapping analysis further demonstrated patients in Stemness Subtype I were more likely to respond to immunotherapy, especially anti-PD1 treatment. The pRRophetic algorithm also indicated patients in Stemness Subtype I were more resistant to temozolomide therapy. Finally, multiple machine learning algorithms were used to develop a 7-gene Stemness Subtype Predictor, which were further validated in two external independent GBM cohorts. This novel stemness-based classification could provide a promising prognostic predictor for GBM and may guide physicians in selecting potential responders for preferential use of immunotherapy.<\/jats:p>","DOI":"10.1093\/bib\/bbab032","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T20:09:59Z","timestamp":1615493399000},"source":"Crossref","is-referenced-by-count":119,"title":["Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients"],"prefix":"10.1093","volume":"22","author":[{"given":"Zihao","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-0499","authenticated-orcid":false,"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuekun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gao","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"2021090815133840400_ref1","first-page":"1531","article-title":"2016 World Health Organization classification of central nervous system Tumors","volume":"23","author":"Wen","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"key":"2021090815133840400_ref2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","article-title":"CGCG clinical practice guidelines for the management of adult diffuse gliomas","volume":"375","author":"Jiang","year":"2016","journal-title":"Cancer Lett"},{"key":"2021090815133840400_ref3","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance Temozolomide vs maintenance Temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"2021090815133840400_ref4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"2021090815133840400_ref5","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2015.61.5005","article-title":"Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and Temozolomide: retrospective analysis of the AVAglio trial","volume":"33","author":"Sandmann","year":"2015","journal-title":"J Clin Oncol"},{"key":"2021090815133840400_ref6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies Stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"2021090815133840400_ref7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc1740","article-title":"Opinion: the origin of the cancer stem cell: current controversies and new insights","volume":"5","author":"Bjerkvig","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2021090815133840400_ref8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2021090815133840400_ref9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2017.03.042","article-title":"Stem cell lineage infidelity drives wound repair and cancer","volume":"169","author":"Ge","year":"2017","journal-title":"Cell"},{"key":"2021090815133840400_ref10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-015-1729-x","article-title":"Glioblastoma stem cells and stem cell-targeting immunotherapies","volume":"123","author":"Esparza","year":"2015","journal-title":"J Neurooncol"},{"key":"2021090815133840400_ref11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"2021090815133840400_ref12","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N Engl J Med"},{"key":"2021090815133840400_ref13","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1038\/ncomms5196","article-title":"Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells","volume":"5","author":"Watkins","year":"2014","journal-title":"Nat Commun"},{"key":"2021090815133840400_ref14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"2021090815133840400_ref15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol"},{"key":"2021090815133840400_ref16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/21645515.2020.1782692","article-title":"1\/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential","volume":"17","author":"Yang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2021090815133840400_ref17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and therapeutic implications of hypermutation in gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature"},{"key":"2021090815133840400_ref18","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","article-title":"Immune checkpoint inhibition for Hypermutant glioblastoma Multiforme resulting from germline Biallelic mismatch repair deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J Clin Oncol"},{"key":"2021090815133840400_ref19","article-title":"Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"2021090815133840400_ref20","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","article-title":"Use of within-array replicate spots for assessing differential expression in microarray experiments","volume":"21","author":"Smyth","year":"2005","journal-title":"Bioinformatics"},{"key":"2021090815133840400_ref21","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"2021090815133840400_ref22","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","article-title":"GenVisR: genomic visualizations in R","volume":"32","author":"Skidmore","year":"2016","journal-title":"Bioinformatics"},{"key":"2021090815133840400_ref23","article-title":"Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden","volume":"7","author":"Budczies","year":"2018","journal-title":"Onco Targets Ther"},{"key":"2021090815133840400_ref24","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2021090815133840400_ref25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an R package for Circos 2D track plots","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2021090815133840400_ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004790","article-title":"Pathway-based genomics prediction using generalized elastic net","volume":"12","author":"Sokolov","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2021090815133840400_ref27","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"2021090815133840400_ref28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"2021090815133840400_ref29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"2021090815133840400_ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"Gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2021090815133840400_ref31","article-title":"Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts","author":"Zhang","year":"2020","journal-title":"Brief Bioinform"},{"key":"2021090815133840400_ref32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"2021090815133840400_ref33","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2021090815133840400_ref34","doi-asserted-by":"crossref","first-page":"W130","DOI":"10.1093\/nar\/gkx356","article-title":"WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2021090815133840400_ref35","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"2021090815133840400_ref36","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1038\/srep06207","article-title":"Critical limitations of consensus clustering in class discovery","volume":"4","author":"\u015eenbabao\u011flu","year":"2014","journal-title":"Sci Rep"},{"key":"2021090815133840400_ref37","doi-asserted-by":"crossref","first-page":"18297","DOI":"10.18632\/aging.103695","article-title":"Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patients","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2021090815133840400_ref38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1878-0261.12639","article-title":"Metabolism-associated molecular classification of hepatocellular carcinoma","volume":"14","author":"Yang","year":"2020","journal-title":"Mol Oncol"},{"key":"2021090815133840400_ref39","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"2021090815133840400_ref40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001195","article-title":"Subclass mapping: identifying common subtypes in independent disease data sets","volume":"2","author":"Hoshida","year":"2007","journal-title":"PLoS One"},{"key":"2021090815133840400_ref41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"2021090815133840400_ref42","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol"},{"key":"2021090815133840400_ref43","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2021090815133840400_ref44","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1002\/sim.3148","article-title":"Selection of important variables and determination of functional form for continuous predictors in multivariable model building","volume":"26","author":"Sauerbrei","year":"2007","journal-title":"Stat Med"},{"key":"2021090815133840400_ref45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1504\/IJDMB.2014.064889","article-title":"Margin-maximised redundancy-minimised SVM-RFE for diagnostic classification of mammograms","volume":"10","author":"Kim","year":"2014","journal-title":"Int J Data Min Bioinform"},{"key":"2021090815133840400_ref46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12883-020-01672-w","article-title":"Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis","volume":"20","author":"Yperman","year":"2020","journal-title":"BMC Neurol"},{"key":"2021090815133840400_ref47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3389\/fgene.2019.01077","article-title":"Gene expression value prediction based on XGBoost algorithm","volume":"10","author":"Li","year":"2019","journal-title":"Front Genet"},{"key":"2021090815133840400_ref48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat Mater"},{"key":"2021090815133840400_ref49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ebiom.2019.08.064","article-title":"Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma","volume":"47","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"key":"2021090815133840400_ref50","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/NEN.0b013e3181c391be","article-title":"Diagnostic use of IDH1\/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues","volume":"68","author":"Horbinski","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021090815133840400_ref51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/modpathol.2014.94","article-title":"TERT promoter mutations contribute to subset prognostication of lower-grade gliomas","volume":"28","author":"Chan","year":"2015","journal-title":"Mod Pathol"},{"key":"2021090815133840400_ref52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bpa.12367","article-title":"Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel","volume":"27","author":"Zacher","year":"2017","journal-title":"Brain Pathol"},{"key":"2021090815133840400_ref53","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1158\/1078-0432.CCR-09-0867","article-title":"Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p\/19q loss","volume":"15","author":"Snuderl","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2021090815133840400_ref54","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ijc.27385","article-title":"Predictive impact of MGMT promoter methylation in glioblastoma of the elderly","volume":"131","author":"Reifenberger","year":"2012","journal-title":"Int J Cancer"},{"key":"2021090815133840400_ref55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2021090815133840400_ref56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"2021090815133840400_ref57","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind","volume":"18","author":"Weller","year":"2017","journal-title":"international phase 3 trial, Lancet Oncol"},{"key":"2021090815133840400_ref58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-019-1085-3","article-title":"Challenges and potential of PD-1\/PD-L1 checkpoint blockade immunotherapy for glioblastoma","volume":"38","author":"Wang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"2021090815133840400_ref59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1101\/gad.261982.115","article-title":"Cancer stem cells in glioblastoma","volume":"29","author":"Lathia","year":"2015","journal-title":"Genes Dev"},{"key":"2021090815133840400_ref60","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","article-title":"Immunobiological characterization of cancer stem cells isolated from glioblastoma patients","volume":"16","author":"Di Tomaso","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2021090815133840400_ref61","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro Oncol"},{"key":"2021090815133840400_ref62","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1158\/0008-5472.CAN-06-2048","article-title":"Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas","volume":"66","author":"Pellegatta","year":"2006","journal-title":"Cancer Res"},{"key":"2021090815133840400_ref63","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/stem.102","article-title":"Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens","volume":"27","author":"Xu","year":"2009","journal-title":"Stem Cells"},{"key":"2021090815133840400_ref64","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/CAD.0b013e328364312f","article-title":"The tricyclic antidepressant amitriptyline is cytotoxic to HTB114 human leiomyosarcoma and induces p75(NTR)-dependent apoptosis","volume":"24","author":"Pula","year":"2013","journal-title":"Anticancer Drugs"},{"key":"2021090815133840400_ref65","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","article-title":"A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors","volume":"3","author":"Jahchan","year":"2013","journal-title":"Cancer Discov"},{"key":"2021090815133840400_ref66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejphar.2015.06.007","article-title":"Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder cancer cells and inhibits bladder tumor growth in vivo","volume":"761","author":"Yuan","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"2021090815133840400_ref67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2017.01.017","article-title":"Amitriptyline down-regulates coenzyme Q(10) biosynthesis in lung cancer cells","volume":"797","author":"Ortiz","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2021090815133840400_ref68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2011.08.093","article-title":"The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells","volume":"413","author":"Jeon","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2021090815133840400_ref69","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00280-017-3329-2","article-title":"Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme","volume":"79","author":"Bielecka-Wajdman","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"2021090815133840400_ref70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A restricted cell population propagates glioblastoma growth after chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"key":"2021090815133840400_ref71","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"2021090815133840400_ref72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/stem.261","article-title":"Notch promotes radioresistance of glioma stem cells","volume":"28","author":"Wang","year":"2010","journal-title":"Stem Cells"},{"key":"2021090815133840400_ref73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"2021090815133840400_ref74","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cdd.2013.136","article-title":"Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells","volume":"21","author":"Venere","year":"2014","journal-title":"Cell Death Differ"},{"key":"2021090815133840400_ref75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stemcr.2014.12.006","article-title":"EZH2 protects glioma stem cells from radiation-induced cell death in a MELK\/FOXM1-dependent manner","volume":"4","author":"Kim","year":"2015","journal-title":"Stem Cell Reports"},{"key":"2021090815133840400_ref76","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","article-title":"Temozolomide for immunomodulation in the treatment of glioblastoma","volume":"20","author":"Karachi","year":"2018","journal-title":"Neuro Oncol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab032\/40260333\/bbab032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab032\/40260333\/bbab032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:02:56Z","timestamp":1671602576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab032\/6220175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab032","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,4,12]]},"article-number":"bbab032"}}